We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Wingspan Stent to Remain on Market, But With Stricter Indications for Use
Wingspan Stent to Remain on Market, But With Stricter Indications for Use
August 10, 2012
The FDA Wednesday said it is limiting use of Stryker’s Wingspan brain stent, but stopped short of removing the device from the market entirely — as consumer advocates had urged.